leadf
logo-loader
viewNovamind Inc
(
CSE:NM
)

Novamind looks to scale mental health clinics and clinical sites with shift in psychedelics policies

Novamind Inc. (CSE:NM) CEO Yaron Conforti tells Proactive the Toronto-based group is looking to scale its mental health clinics and its clinical research sites as policy around psychedelic drugs shifts in the US and around the world. Conforti says part of the group's plan when it chose to go public, was to expand its reach into the US. The group currently has mental health clinics in various locations in Utah, and offers its clients access to ketamine therapies.

Quick facts: Novamind Inc

Follow
CSE:NM

Price: 0.63 CAD

Market Cap: $26.16 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Empower Clinic’s Medi-Collective expands future locations to 33 covering BC,...

Empower Clinics CEO Steven McAuley joined Steve Darling from Proactive to shares news the company is expanding their national clinic rollout strategy and are preparing to open their next Medi-Collective" clinic in Etobicoke, Ontario on October 18th. McAuley also shared with Proactive the...

2 hours, 5 minutes ago

2 min read